Furthermore, EPHA2 in GBM seems to regulate the expression of epidermal growth factor receptor (EGFR) and vascular endothelial growth factor receptor 2 (VEGFR-2), which constitute the initial biomarkers of the development of endothelial cells in the neovascularisation process [119]. This evidence concerns the gene EGFR and glioblastoma.